These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11815570)

  • 1. Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests.
    Livermore DM; Struelens M; Amorim J; Baquero F; Bille J; Canton R; Henning S; Gatermann S; Marchese A; Mittermayer H; Nonhoff C; Oakton KJ; Praplan F; Ramos H; Schito GC; Van Eldere J; Verhaegen J; Verhoef J; Visser MR
    J Antimicrob Chemother; 2002 Feb; 49(2):289-300. PubMed ID: 11815570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility testing and resistance phenotypes detection in bacterial pathogens using the VITEK 2 System.
    Stefaniuk E; Mrówka A; Hryniewicz W
    Pol J Microbiol; 2005; 54(4):311-6. PubMed ID: 16599303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of Vitek 2 performance for identifying extended spectrum beta-lactamases in Enterobacteriaceae "other than Escherichia coli, Proteus mirabilis and Klebsiella spp"].
    Diamante P; Camporese A
    Infez Med; 2006 Dec; 14(4):216-26. PubMed ID: 17380089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals.
    Barry J; Brown A; Ensor V; Lakhani U; Petts D; Warren C; Winstanley T
    J Antimicrob Chemother; 2003 May; 51(5):1191-202. PubMed ID: 12697635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Vitek-2 extended-spectrum beta-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases.
    Robin F; Delmas J; Schweitzer C; Bonnet R
    Clin Microbiol Infect; 2008 Feb; 14(2):148-54. PubMed ID: 18076663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
    Sanders CC; Peyret M; Moland ES; Shubert C; Thomson KS; Boeufgras JM; Sanders WE
    J Clin Microbiol; 2000 Feb; 38(2):570-4. PubMed ID: 10655347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Uro-Quick, a new rapid automated system, for the detection of well-characterized antibiotic-resistant bacteria.
    Roveta S; Marchese A; Debbia EA
    J Chemother; 2004 Apr; 16(2):107-18. PubMed ID: 15216942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital.
    Sanders CC; Peyret M; Moland ES; Cavalieri SJ; Shubert C; Thomson KS; Boeufgras JM; Sanders WE
    J Clin Microbiol; 2001 Jul; 39(7):2379-85. PubMed ID: 11427542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students.
    Chirindze LM; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Sundsfjord A; Essack SY; Simonsen GS
    BMC Infect Dis; 2018 May; 18(1):244. PubMed ID: 29843632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of VITEK 2 for analysis of Enterobacteriaceae using the Advanced Expert System (AES) versus interpretive susceptibility guidelines used at Dynacare Kasper Medical Laboratories, Edmonton, Alberta.
    Blondel-Hill E; Hetchler C; Andrews D; Lapointe L
    Clin Microbiol Infect; 2003 Nov; 9(11):1091-103. PubMed ID: 14616725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory-based evaluation of the colorimetric VITEK-2 Compact system for species identification and of the Advanced Expert System for detection of antimicrobial resistances: VITEK-2 Compact system identification and antimicrobial susceptibility testing.
    Nakasone I; Kinjo T; Yamane N; Kisanuki K; Shiohira CM
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):191-8. PubMed ID: 17300904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles.
    Livermore DM; Mushtaq S; Meunier D; Hopkins KL; Hill R; Adkin R; Chaudhry A; Pike R; Staves P; Woodford N;
    J Antimicrob Chemother; 2017 Aug; 72(8):2278-2289. PubMed ID: 28520867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MULTIRESISTANT BACTERIA].
    Bedenić B; Sardelić S; Ladavac M
    Acta Med Croatica; 2015 Sep; 69(3):211-6. PubMed ID: 29077379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
    Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L
    Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of faropenem against cephalosporin-resistant Enterobacteriaceae.
    Mushtaq S; Hope R; Warner M; Livermore DM
    J Antimicrob Chemother; 2007 May; 59(5):1025-30. PubMed ID: 17353220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.